Ovoca Bio's Libicore Application Result Expected A Year After Filing
(Alliance News) - Ovoca Bio PLC on Thursday said it intends to file for the approval of its Libicore female sexual dysfunction drug later in the quarter and expects the verdict in a year's 16% Read More